{"prompt": "['Boehringer Ingelheim', '16 Dec 2019', 'BI Trial No.: 1199-0324', 'c19558808-06', 'Clinical Trial Protocol', 'Page 45 of 103', 'Proprietary confidential information \u00a9 2019 Boehringer Ingelheim International GmbH or one or more of its affiliated companies', 'The statistical analysis will be based on the following populations:', 'Randomized Set (RS): The Randomised set (RS) consists of those patients who were', 'randomized to an intervention.', 'The efficacy will be conducted on the Randomized Set. For efficacy analysis, all', 'measurements performed within visits 2-7 will be used.', 'Although there is no per protocol data set in the study, reasons for important protocol', 'violations will be specified in the Trial Statistical Analysis Plan (TSAP). Patients with', 'potential important protocol violations (those that relate to patient safety or efficacy) will be', 'identified at Blinded Review Planning Meetings and listed in the clinical trial.', '7.3.1', 'Primary endpoint analyses', 'The primary analysis is a restricted maximum likelihood (REML) based analysis of', 'covariance (ANCOVA) comparing the change from baseline of 6MWD after 12 weeks of', 'treatment with adjustment for the covariates of intervention as a fixed categorical covariate', 'and baseline 6MWD value as a continuous covariate.', 'The statistical model will be as follows:', 'Yij = response variable for the subject i receiving intervention j', 'B = fixed effect regression coefficient of baseline effect', 'Si = the baseline measurement of subject i, i = 1,2, where the baseline', 'measurement is collected on Day 1 of the interventional period', 'Tj = the fixed effect of intervention j, j = 1, 2', 'ei = the random error associated with the ith subject, identically independent', 'normally distributed with mean 0 and unknown variance 02', 'The Kenward-Roger approximation will be used to estimate denominator degrees of freedom', 'and adjust standard errors. Significance tests will be based on least-squares means using a', 'two-sided a = 0.05 (two-sided 95% confidence intervals). The primary intervention', 'comparison will be the least-squares means contrast between interventions. Primary endpoint', 'analyses will be done on complete cases. Section 7.3.2 discusses planned sensitivity analysis', 'to assess the impact of patients missing post-randomisation data.', '7.3.2', 'Secondary endpoint analyses', 'The secondary endpoints include those listed in Section 5.1.1.2. All other secondary', 'endpoints will be analysed on the original scales.', '01-MCS-40-106-RD-03 (14.0) / Saved on: 17 October 2016']['Boehringer Ingelheim', '16 Dec 2019', 'BI Trial No.: 1199-0324', 'c19558808-06', 'Clinical Trial Protocol', 'Page 46 of 103', 'Proprietary confidential information \u00a9 2019 Boehringer Ingelheim International GmbH or one or more of its affiliated companies', 'The 12-week secondary endpoints will be analysed equivalently as the primary endpoint', 'using the ANCOVA model including intervention as a fixed categorical covariate and', 'baseline value as a continuous covariate.', 'The 24-week secondary endpoints will be analysed with a restricted maximum likelihood', '(REML) based approach using a mixed model with repeated measurements (MMRM)', 'comparing the change from baseline after 24 weeks of intervention. The analysis will include', 'the fixed, categorical effects of intervention and the fixed continuous effects of baseline at', 'each visit. Visit will be treated as the repeated measure with an unstructured covariance', 'structure used to model the within-patient measurements. The statistical model will be as', 'follows:', 'eij~N2(0,2)', 'Yijk = response variable for the subject i at visit j receiving intervention k,', 'Bi = coefficient of baseline effect at visit j,', 'Si = the baseline measurement of subject i, i = 1,2,', 'Tjk = the effect of intervention k at visit_ j; j = 1, 2 (3) and k = 1, 2', 'eij = the random error associated with the jth visit of the ith subject, Errors are', 'independent between subjects,', '= an unstructured covariance matrix.', 'The Kenward-Roger approximation will be used to estimate denominator degrees of freedom', 'and adjust standard errors. Significance tests will be based on least-squares means using a', 'two-sided a = 0.05 (two-sided 95% confidence intervals). The primary intervention', 'comparison will be the least-squares means contrast between treatments.', 'A sensitivity analysis of the primary analysis will be performed using multiple imputation to', 'handle missing data. All variables included in the analysis model will be included in the', 'imputation model. In addition, after exploring the missing data mechanism and observed', 'measurements on the blinded data, additional variables may be included in the imputation', 'model, based on their associations with the observed endpoint value and/or the missingness', 'mechanism. Those variables will be identified in the TSAP. For each imputed complete', 'dataset, the primary analysis model will be used for the analysis. The results will be pooled', 'following the standard multiple imputation procedure.', '001-MCS-40-106-RD-03 (14.0) / Saved on: 17 October 2016']\n\n###\n\n", "completion": "END"}